文献速递免疫规划

激光辅助皮内递送微粒疫苗诱导呼吸道合胞病毒强效免疫应答

Laser-assisted intradermal delivery of a microparticle vaccine for respiratory syncytial virus induces a robust immune response.
PubMed 文献 · Vaccine · 2023-01-09

本研究将呼吸道合胞病毒融合蛋白病毒样颗粒封装于交联牛血清白蛋白微粒中,并加入单磷酸酰脂质A佐剂,利用P.L.E.A.S.E激光在皮肤上创建微孔进行皮内免疫。瑞士韦伯斯特小鼠免疫后血清IgG和IgG2a升高,提示Th1应答;攻毒后肺匀浆IgA升高,淋巴结和脾脏CD8+、CD4+表达增高,脾细胞干扰素γ表达增加,肺病毒滴度显著降低。作者认为该激光辅助皮内免疫微粒疫苗可能是RSV的有前景候选疫苗。

要点

  • F-VLP微粒疫苗联合MPL-A佐剂经激光皮内免疫小鼠,诱导Th1型免疫应答。
  • 免疫小鼠攻毒后肺匀浆IgA升高,提示产生黏膜免疫应答。
  • 免疫小鼠肺病毒滴度显著降低。

核心结论

  • 激光辅助皮内免疫F-VLP佐剂微粒疫苗可能是RSV的有前景候选疫苗。

研究设计与样本

  • 研究将RSV融合蛋白病毒样颗粒封装于交联牛血清白蛋白微粒基质中,并制备含或不含单磷酸酰脂质A佐剂的微粒,在树突状细胞中观察抗原呈递。
  • 使用P.L.E.A.S.E激光在皮肤上创建微孔,对瑞士韦伯斯特小鼠进行皮内免疫以研究体内免疫原性。

主要发现

  • 免疫小鼠血清IgG和IgG2a水平高,提示Th1应答。
  • RSV攻毒后肺匀浆IgA高,提示皮内免疫产生黏膜免疫应答。
  • 流式细胞术显示佐剂疫苗微粒免疫小鼠淋巴结和脾脏CD8+和CD4+表达高。
  • 脾细胞干扰素γ表达增加,进一步证明Th1极化免疫应答。
  • 免疫斑块试验显示皮内佐剂疫苗微粒免疫小鼠肺病毒滴度显著低。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Respiratory syncytial virus (RSV) is an infectious disease that poses a significant public health risk in young children. Vaccine studies conducted in the 1960s using an intramuscular injection of formalin-inactivated respiratory syncytial virus (Fi-RSV) resulted in an enhanced respiratory disease and led to the failure of the vaccine. Thus, the virus-like particles (VLP) of the RSV fusion (F) protein was used as the vaccine antigen in this study. The F-VLP was encapsulated in a microparticle (MP) matrix composed of cross-linked bovine serum albumin (BSA) to enhance the antigen presentation and uptake. Moreover, a painless vaccination method would be desirable for an infectious disease that mainly affects young children. Thus, an ablative laser device, Precise Laser Epidermal System (P.L.E.A.S.E), was utilized to create micropores on the skin for vaccine delivery. We observed enhanced antigen presentation of the vaccine microparticles (F-VLP MP) with and without the adjuvant monophosphoryl lipid A (MPL-A) MP in dendritic cells. Consequently, Swiss Webster mice were immunized with the adjuvanted vaccine microparticles using the P.L.E.A.S.E laser to study the in vivo immunogenicity. The immunized mice had high serum immunoglobulin (IgG, IgG2a) levels, indicating a Th1 response. Subsequent analysis of lung homogenates post- RSV challenge revealed high IgA, indicating generation of a mucosal immune response upon intradermal immunization. Flowcytometry analysis showed high CD8+, and CD4+ expression in the lymph node and spleen of the adjuvanted vaccine microparticle immunized mice. Increased expression of interferon gamma (IFN-γ) in the spleen cells further proved Th1 polarized immune response. Finally, an immune plaque assay indicated significantly low lung viral titer in the mice immunized with intradermal adjuvanted vaccine microparticles. Thus, ablative laser-assisted immunization with the F-VLP based adjuvanted vaccine microparticles could be a promising vaccine candidate for RSV.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Menon I, Kang SM, Braz Gomes K, et al. Laser-assisted intradermal delivery of a microparticle vaccine for respiratory syncytial virus induces a robust immune response. Vaccine. 2023. PMID: 36631361. doi:10.1016/j.vaccine.2023.01.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。